Skip to content
10-Q

Quarterly Report

Edwards Lifesciences Corp EW

0001099800-25-000048

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 587.1M sh
Shares Diluted Q2 2025 · Jun 30, 2025 587.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 587.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 604.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 604.2M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $264.1M
Stock Repurchased Q2 2025 · Jun 30, 2024 $158.3M
Capex Q2 2025 · Jun 30, 2025 $105.3M
Capex Q2 2025 · Jun 30, 2024 $150.7M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $570.6M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $318M
Long Term Debt Q2 2025 · Jun 30, 2025 $598M
Long Term Debt Q2 2025 · Dec 31, 2024 $597.7M
Short Term Investments Q2 2025 · Jun 30, 2025 $789.4M
Short Term Investments Q2 2025 · Dec 31, 2024 $930.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.27B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.05B
Stockholders Equity Q2 2025 · Jun 30, 2025 $10.55B
Stockholders Equity Q2 2025 · Dec 31, 2024 $10B
Current Liabilities Q2 2025 · Jun 30, 2025 $1.4B
Current Liabilities Q2 2025 · Dec 31, 2024 $1.51B
Total Liabilities Q2 2025 · Jun 30, 2025 $2.88B
Total Liabilities Q2 2025 · Dec 31, 2024 $2.99B
Current Assets Q2 2025 · Jun 30, 2025 $6.58B
Current Assets Q2 2025 · Dec 31, 2024 $6.29B
Total Assets Q2 2025 · Jun 30, 2025 $13.49B
Total Assets Q2 2025 · Dec 31, 2024 $13.06B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.56
Eps Diluted Q2 2025 · Jun 30, 2025 $1.18
Eps Diluted Q2 2025 · Jun 30, 2024 $0.61
Eps Diluted Q2 2025 · Jun 30, 2024 $1.19
Eps Basic Q2 2025 · Jun 30, 2025 $0.57
Eps Basic Q2 2025 · Jun 30, 2025 $1.18
Eps Basic Q2 2025 · Jun 30, 2024 $0.61
Eps Basic Q2 2025 · Jun 30, 2024 $1.19
Sga Expense Q2 2025 · Jun 30, 2025 $502M
Sga Expense Q2 2025 · Jun 30, 2025 $967.7M
Sga Expense restated Q2 2025 · Jun 30, 2024 $447.5M
Sga Expense restated Q2 2025 · Jun 30, 2024 $875.9M
Rd Expense Q2 2025 · Jun 30, 2025 $276.2M
Rd Expense Q2 2025 · Jun 30, 2025 $530.8M
Rd Expense restated Q2 2025 · Jun 30, 2024 $271.8M
Rd Expense restated Q2 2025 · Jun 30, 2024 $528.5M
Net Income Q2 2025 · Jun 30, 2025 $333.2M
Net Income Q2 2025 · Jun 30, 2025 $691.2M
Net Income Q2 2025 · Jun 30, 2024 $366.3M
Net Income Q2 2025 · Jun 30, 2024 $718.2M
Operating Income Q2 2025 · Jun 30, 2025 $411.2M
Operating Income Q2 2025 · Jun 30, 2025 $806M
Operating Income restated Q2 2025 · Jun 30, 2024 $366.5M
Operating Income restated Q2 2025 · Jun 30, 2024 $715.5M
Gross Profit Q2 2025 · Jun 30, 2025 $1.19B
Gross Profit Q2 2025 · Jun 30, 2025 $2.3B
Gross Profit restated Q2 2025 · Jun 30, 2024 $1.09B
Gross Profit restated Q2 2025 · Jun 30, 2024 $2.14B
Cost Of Revenue Q2 2025 · Jun 30, 2025 $344.4M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $646M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $275.5M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $562.4M
Revenue Q2 2025 · Jun 30, 2025 $1.53B
Revenue Q2 2025 · Jun 30, 2025 $2.94B
Revenue restated Q2 2025 · Jun 30, 2024 $1.37B
Revenue restated Q2 2025 · Jun 30, 2024 $2.7B